Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes -

June 12, 2019

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

See file

Back

Last related news

March 6, 2023

The Brazilian Data Protection Authority (“ANPD” or “Authority”) published, on February 28th, 2023, the Regulation on Dosimetry and Application of Administrative Penalties … Brazilian Data Protection Authority approves the Regulation on Dosimetry and Application of Administrative Penalties

January 17, 2023

Several Bills are being debated in the Brazilian National Congress with the objective of regulating the development and use of artificial intelligence … The Future Legal Regulation Of Artificial Intelligence In Brazil

January 9, 2023

In the last days of December 2022, new regulations entered into force easing up the remittance of royalty payments abroad. However, local … New flexibility on the remittance of royalty payments abroad